MCID: LYM035
MIFTS: 20

Lymphangiectasis malady

Categories: Rare diseases, Immune diseases

Aliases & Classifications for Lymphangiectasis

About this section

Aliases & Descriptions for Lymphangiectasis:

Name: Lymphangiectasis 45 65
 
Lymphangiectasia 45

Classifications:



External Ids:

UMLS65 C0024214

Summaries for Lymphangiectasis

About this section
Wikipedia:68 Lymphangiectasia is a pathologic dilation of lymph vessels. When it occurs in the intestines of dogs,... more...

MalaCards based summary: Lymphangiectasis, also known as lymphangiectasia, is related to hennekam lymphangiectasia-lymphedema syndrome 2 and hennekam lymphangiectasia-lymphedema syndrome 1. Affiliated tissues include t cells, endothelial and heart.

Related Diseases for Lymphangiectasis

About this section

Graphical network of the top 20 diseases related to Lymphangiectasis:



Diseases related to lymphangiectasis

Symptoms for Lymphangiectasis

About this section

Drugs & Therapeutics for Lymphangiectasis

About this section

Drugs for Lymphangiectasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Sirolimusapproved, investigationalPhase 2179753123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
2
Miconazoleapproved, investigationalPhase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
3
EverolimusapprovedPhase 21797159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
Afinitor Disperz
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
VOTUBIA
Zortress
everolimus
4Antifungal AgentsPhase 23015
5Antibiotics, AntitubercularPhase 25971
6Immunosuppressive AgentsPhase 210422
7Immunologic FactorsPhase 218483
8Anti-Bacterial AgentsPhase 29140
9Anti-Infective AgentsPhase 217220

Interventional clinical trials:

idNameStatusNCT IDPhase
1Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
2Characterization of the Pathogenesis of Primary and Secondary Lymphatic DisordersRecruitingNCT02156115
3National Lymphatic Disease and Lymphedema RegistryRecruitingNCT01336790

Search NIH Clinical Center for Lymphangiectasis

Genetic Tests for Lymphangiectasis

About this section

Anatomical Context for Lymphangiectasis

About this section

MalaCards organs/tissues related to Lymphangiectasis:

33
T cells, Endothelial, Heart, Prostate, Cardiac myocytes, Hypothalamus, Testes

Animal Models for Lymphangiectasis or affiliated genes

About this section

Publications for Lymphangiectasis

About this section

Articles related to Lymphangiectasis:

(show top 50)    (show all 119)
idTitleAuthorsYear
1
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain. (26973529)
2016
2
Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC. (24842609)
2014
3
Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients. (24919441)
2014
4
Peripheral Cone Dystrophy: A Diagnostic Improbability? (24705257)
2014
5
Meralgia paresthetica: a review of the literature. (24377074)
2013
6
Diffuse gastric mantle cell lymphoma resembling gastrointestinal stromal tumors. (24368075)
2013
7
Do predictors of incomplete Kawasaki disease exist for infants? (23001516)
2013
8
Post-surgical lipophagic panniculitis: a specific model of traumatic panniculitis and new histopathological findings. (23900165)
2013
9
Well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst. (23294072)
2012
10
A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7. (22595804)
2012
11
4D CT--A diagnostic tool to localize an occult parathyroid adenoma in a patient with primary hyperparathyroidism. (22808636)
2012
12
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. (22577108)
2012
13
Malformations in a cohort of 284 women with Mayer-Rokitansky-KA1ster-Hauser syndrome (MRKH). (22906151)
2012
14
Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells. (21316663)
2011
15
Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus). (20357218)
2010
16
Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. (19546243)
2009
17
Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection. (19561432)
2009
18
A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells. (19035465)
2009
19
Chronic ethanol exposure induces alterations in the nucleocytoplasmic transport in growing astrocytes. (18547370)
2008
20
Expression of periostin and the effect of hydrocortisone on it in human fibroblasts of scar]. (18560459)
2008
21
Performance of the urine leukocyte esterase and nitrite dipstick test for the diagnosis of acute prostatitis. (18288905)
2008
22
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. (17941058)
2008
23
An efficient and economic high-throughput cell screening model targeting the glucocorticoid receptor. (18172821)
2008
24
The innate immune system in SLE: type I interferons and dendritic cells. (18490415)
2008
25
HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. (17675567)
2007
26
Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. (17904225)
2007
27
Does human attractin have DP4 activity? (17261078)
2007
28
An ent-kaurene that inhibits mitotic chromosome movement and binds the kinetochore protein ran-binding protein 2. (17168522)
2006
29
Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing. (16495236)
2006
30
Role of MKK3 and p38 MAPK in cytokine-induced death of insulin-producing cells. (16097952)
2006
31
Gene therapy for Parkinson's disease: progress and challenges. (15638712)
2005
32
Adipose tissue: a regulator of inflammation. (16311216)
2005
33
Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifying UGA codons. (15791204)
2005
34
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. (15183454)
2004
35
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. (15555999)
2004
36
Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. (12654916)
2003
37
Slow and persistent increase of [Ca2+]c in response to ligation of surface IgM in WEHI-231 cells. (12560088)
2003
38
CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosis. (12626576)
2003
39
Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter. (12163988)
2002
40
Detection of level and mutation of neurofilament mRNA in Alzheimer's disease]. (12133495)
2002
41
Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. (12021253)
2002
42
Effect of destructive pulse duration on the detection of myocardial perfusion in myocardial contrast echocardiography: In vitro and in vivo observations. (12464909)
2002
43
Gonadal sex cord stromal tumor in a patient with Rubinstein-Taybi syndrome. (11982910)
2002
44
Neuropathological features of mitochondrial disorders. (11735377)
2001
45
TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis. (11098060)
2001
46
Alteration of interferon-gamma and interleukin-12 released by bronchoalveolar lavage cells from pulmonary tuberculosis]. (11778531)
2000
47
9p21 deletion correlates with recurrence in head and neck cancer. (9484941)
1998
48
Usefulness of sequential urinary follicle-stimulating hormone and luteinizing hormone measurements in the diagnosis of adolescent hypogonadotropism in males. (8175980)
1994
49
The rate of formation of transition-state analogues in the active site of adenosine deaminase is encounter-controlled: implications for the mechanism. (1731884)
1992
50
Recovery from severe oligospermia after exposure to dibromochloropropane. (6780379)
1981

Variations for Lymphangiectasis

About this section

Expression for genes affiliated with Lymphangiectasis

About this section
Search GEO for disease gene expression data for Lymphangiectasis.

Pathways for genes affiliated with Lymphangiectasis

About this section

GO Terms for genes affiliated with Lymphangiectasis

About this section

Sources for Lymphangiectasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet